Could a simple blood test predict skin problems from cancer immunotherapy?
NCT ID NCT05689463
Summary
This study aims to understand if patients who develop chronic, widespread itch while receiving certain cancer immunotherapies have specific antibodies in their blood. Researchers will check blood samples from 100 patients to see if these antibodies are present. The goal is to learn if having these antibodies might be linked to developing certain skin conditions later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH CHRONIC PRURITUS FOR MORE THAN 1 MONTH WHO HAVE RECEIVED IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UHRouen
RECRUITINGRouen, France
Contact
Conditions
Explore the condition pages connected to this study.